This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Porter, C. B. Articles by O'Rourke, R. A. Search for Related Content PubMed PubMed Citation Articles by Porter, C. B. Articles by O'Rourke, R. A.

Circulation, Vol 68, 685-692, Copyright © 1983 by American Heart Association

ARTICLES

Differential effects of diltiazem and nitroprusside on left ventricular function in experimental chronic volume overload

CB Porter, RA Walsh, FR Badke and RA O'Rourke

To compare the hemodynamic effects of a calcium-channel blocker with those of a conventional vasodilator in the awake preinstrumented dog, diltiazem and nitroprusside were administered in equihypotensive infusions before (decrease in mean aortic pressure by 10%; p less than .001, n = 6) and after (decrease in mean aortic pressure by 12%; p less than .001) chronic volume overload (CVO) produced by an infrarenal aortocaval fistula. Diltiazem had no effect on preload either before or after CVO. The maximal rate of change in left ventricular pressure (dP/dtmax) was unaffected by diltiazem before the aortocaval fistula (decrease in dP/dtmax by 6%; p = NS) but was significantly reduced by calcium-channel blockade after CVO (decrease in dP/dtmax by 22%; p less than .001). By contrast, at matched aortic pressures nitroprusside significantly reduced left ventricular end-diastolic dimension (LVEDD) and pressure (LVEDP) in the same animals before (decrease in LVEDD by 10%, p less than .05; decrease in LVEDP by 7 +/- 2 mm Hg, p less than .001) and after CVO (decrease in LVEDD by 7%, p less than .05; decrease in LVEDP by 5 +/- 2 mm Hg, p less than .001) without altering dP/dtmax. We conclude that the calcium entry blocker diltiazem, unlike conventional vasodilators, may depress left ventricular function in CVO by direct negative inotropic properties in amounts that are without myocardial depressant effects in the presence of normal left ventricular performance.

This article has been cited by other articles:

				G. Bolotin, R. Lorusso, J. J. Schreuder, H. G. Kaulbach, G. Uretzky, and F. H. van der Veen Effects of acute dynamic cardiomyoplasty in a goat model of chronic ventricular dilatation: part 1 Ann. Thorac. Surg., August 1, 2002; 74(2): 507 - 513. [Abstract] [Full Text] [PDF]

				G. Bolotin, R. Lorusso, J. J. Schreuder, N. Nesher, H. Kaulbach, G. Uretzky, and F. van der Veen Perioperative Hemodynamic and Geometric Changes of the Left Ventricle During Cardiomyoplasty in Goats With Dilated Left Ventricle* Chest, May 1, 2002; 121(5): 1628 - 1633. [Abstract] [Full Text] [PDF]

				S. Sandmann, H. Spitznagel, O. Chung, Qin-Gui Xia, S. Illner, G. Janichen, B. Rossius, M. J.A.P Daemen, and T. Unger Effects of the calcium channel antagonist mibefradil on haemodynamic and morphological parameters in myocardial infarction-induced cardiac failure in rats Cardiovasc Res, August 1, 1998; 39(2): 339 - 350. [Abstract] [Full Text] [PDF]

				H. Shimoyama, H. N. Sabbah, M. Tanimura, S. Borzak, and S. Goldstein Short-Term Hemodynamic Effects of Mibefradil in Dogs With Chronic Heart Failure: Comparison With Diltiazem J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 746 - 752. [Abstract] [Full Text]